Plain-English translation of NCT05552937 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether combining two medications——can help people with a type of blood cancer called diffuse large B-cell lymphoma (DLBCL) that has stopped responding to or returned after earlier treatments. You would receive both medications together for up to 12 cycles (about 12 months), and then continue with one medication alone if the treatment is working well.
Many people with this aggressive lymphoma run out of options after their first or second round of treatment. This trial is exploring whether this medication combination might give patients another effective path forward when standard treatments no longer work.
You likely qualify if…
You likely don't qualify if…
You would visit the study clinic regularly to receive the two medications together for up to 12 months (given in 28-day cycles). If the treatment is working, you would then continue with one medication alone until it stops working or side effects become too much. During the trial, you'll have blood tests and scans to monitor how you're doing, and the doctors will track any side effects carefully.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
China
Phase
Testing effectiveness
Sponsor
Beijing InnoCare Pharma Tech Co., Ltd.
Enrollment target
~50 participants
Started
September 2021
Primary completion
April 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in September 2022.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Huili Zhou
Beijing InnoCare Pharma Tech Co., Ltd.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.